• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用Cas9核糖核蛋白生成基因敲除的原代和扩增人自然杀伤细胞。

Generation of Knock-out Primary and Expanded Human NK Cells Using Cas9 Ribonucleoproteins.

作者信息

Naeimi Kararoudi Meisam, Dolatshad Hamid, Trikha Prashant, Hussain Syed-Rehan A, Elmas Ezgi, Foltz Jennifer A, Moseman Jena E, Thakkar Aarohi, Nakkula Robin J, Lamb Margaret, Chakravarti Nitin, McLaughlin K John, Lee Dean A

机构信息

Center for Childhood Cancer and Blood Disease, Nationwide Children's Hospital.

Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford.

出版信息

J Vis Exp. 2018 Jun 14(136):58237. doi: 10.3791/58237.

DOI:10.3791/58237
PMID:29985369
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6101749/
Abstract

CRISPR/Cas9 technology is accelerating genome engineering in many cell types, but so far, gene delivery and stable gene modification have been challenging in primary NK cells. For example, transgene delivery using lentiviral or retroviral transduction resulted in a limited yield of genetically-engineered NK cells due to substantial procedure-associated NK cell apoptosis. We describe here a DNA-free method for genome editing of human primary and expanded NK cells using Cas9 ribonucleoprotein complexes (Cas9/RNPs). This method allowed efficient knockout of the TGFBR2 and HPRT1 genes in NK cells. RT-PCR data showed a significant decrease in gene expression level, and a cytotoxicity assay of a representative cell product suggested that the RNP-modified NK cells became less sensitive to TGFβ. Genetically modified cells could be expanded post-electroporation by stimulation with irradiated mbIL21-expressing feeder cells.

摘要

CRISPR/Cas9技术正在加速多种细胞类型中的基因组工程,但到目前为止,基因递送和稳定的基因修饰在原代自然杀伤(NK)细胞中一直具有挑战性。例如,使用慢病毒或逆转录病毒转导进行转基因递送,由于与操作相关的大量NK细胞凋亡,导致基因工程化NK细胞的产量有限。我们在此描述一种使用Cas9核糖核蛋白复合物(Cas9/RNPs)对人原代和扩增的NK细胞进行基因组编辑的无DNA方法。该方法能够有效敲除NK细胞中的TGFBR2和HPRT1基因。逆转录聚合酶链反应(RT-PCR)数据显示基因表达水平显著降低,对一种代表性细胞产物的细胞毒性分析表明,经核糖核蛋白(RNP)修饰的NK细胞对转化生长因子β(TGFβ)的敏感性降低。基因修饰的细胞在电穿孔后可通过用表达mbIL21的辐照饲养细胞刺激进行扩增。

相似文献

1
Generation of Knock-out Primary and Expanded Human NK Cells Using Cas9 Ribonucleoproteins.使用Cas9核糖核蛋白生成基因敲除的原代和扩增人自然杀伤细胞。
J Vis Exp. 2018 Jun 14(136):58237. doi: 10.3791/58237.
2
Protocol for genomic editing in human resting primary NK cells and NK-92 cells via CRISPR-Cas9 ribonucleoproteins.通过 CRISPR-Cas9 核糖核蛋白在人静止原代 NK 细胞和 NK-92 细胞中进行基因组编辑的方案。
STAR Protoc. 2024 Sep 20;5(3):103123. doi: 10.1016/j.xpro.2024.103123. Epub 2024 Jun 26.
3
Ex Vivo Expansion and CRISPR-Cas9 Genome Editing of Primary Human Natural Killer Cells.离体扩增和 CRISPR-Cas9 基因组编辑原发性人自然杀伤细胞。
Curr Protoc. 2021 Sep;1(9):e246. doi: 10.1002/cpz1.246.
4
Enhanced NK-92 Cytotoxicity by CRISPR Genome Engineering Using Cas9 Ribonucleoproteins.利用 Cas9 核糖核蛋白进行 CRISPR 基因组工程增强 NK-92 细胞的细胞毒性。
Front Immunol. 2020 May 22;11:1008. doi: 10.3389/fimmu.2020.01008. eCollection 2020.
5
Generation of knock-in primary human T cells using Cas9 ribonucleoproteins.使用Cas9核糖核蛋白生成敲入型原代人T细胞。
Proc Natl Acad Sci U S A. 2015 Aug 18;112(33):10437-42. doi: 10.1073/pnas.1512503112. Epub 2015 Jul 27.
6
A robust platform for expansion and genome editing of primary human natural killer cells.一个用于扩增和基因组编辑原代人自然杀伤细胞的强大平台。
J Exp Med. 2021 Mar 1;218(3). doi: 10.1084/jem.20201529.
7
High-affinity CD16 integration into a CRISPR/Cas9-edited CD38 locus augments CD38-directed antitumor activity of primary human natural killer cells.高亲和力 CD16 整合到 CRISPR/Cas9 编辑的 CD38 基因座中增强了原发性人自然杀伤细胞的 CD38 导向抗肿瘤活性。
J Immunother Cancer. 2022 Feb;10(2). doi: 10.1136/jitc-2021-003804.
8
A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy.用于癌症免疫疗法的基因工程化原发性人自然杀伤细胞平台。
Mol Ther. 2020 Jan 8;28(1):52-63. doi: 10.1016/j.ymthe.2019.10.009. Epub 2019 Oct 15.
9
Efficient generation of isogenic primary human myeloid cells using CRISPR-Cas9 ribonucleoproteins.使用 CRISPR-Cas9 核糖核蛋白高效生成同基因原代人髓系细胞。
Cell Rep. 2021 May 11;35(6):109105. doi: 10.1016/j.celrep.2021.109105.
10
CRISPR/Cas9; A robust technology for producing genetically engineered plants.CRISPR/Cas9:一种用于培育基因工程植物的强大技术。
Cell Mol Biol (Noisy-le-grand). 2018 Nov 30;64(14):31-38.

引用本文的文献

1
Precision enhancement of CAR-NK cells through non-viral engineering and highly multiplexed base editing.通过非病毒工程和高度多重碱基编辑提高CAR-NK细胞的精准度。
J Immunother Cancer. 2025 May 7;13(5):e009560. doi: 10.1136/jitc-2024-009560.
2
PM21-particle stimulation augmented with cytokines enhances NK cell expansion and confers memory-like characteristics with enhanced survival.PM21 颗粒刺激联合细胞因子增强 NK 细胞扩增,并赋予其具有增强存活能力的记忆样特征。
Front Immunol. 2024 Apr 22;15:1383281. doi: 10.3389/fimmu.2024.1383281. eCollection 2024.
3
Precision Enhancement of CAR-NK Cells through Non-Viral Engineering and Highly Multiplexed Base Editing.通过非病毒工程和高度多重碱基编辑提高CAR-NK细胞的精准度
bioRxiv. 2024 Mar 8:2024.03.05.582637. doi: 10.1101/2024.03.05.582637.
4
Knockout of the inhibitory receptor TIGIT enhances the antitumor response of ex vivo expanded NK cells and prevents fratricide with therapeutic Fc-active TIGIT antibodies.敲除抑制性受体 TIGIT 可增强体外扩增 NK 细胞的抗肿瘤反应,并防止与治疗性 Fc 活性 TIGIT 抗体发生自相残杀。
J Immunother Cancer. 2023 Dec 11;11(12):e007502. doi: 10.1136/jitc-2023-007502.
5
Efficient and stable CRISPR/Cas9-mediated genome-editing of human type 2 innate lymphoid cells.高效稳定的 CRISPR/Cas9 介导的人类 2 型固有淋巴细胞基因组编辑。
Front Immunol. 2023 Oct 5;14:1275413. doi: 10.3389/fimmu.2023.1275413. eCollection 2023.
6
Innovative Strategies of Reprogramming Immune System Cells by Targeting CRISPR/Cas9-Based Genome-Editing Tools: A New Era of Cancer Management.靶向基于 CRISPR/Cas9 的基因组编辑工具的免疫系统细胞重编程创新策略:癌症管理的新时代。
Int J Nanomedicine. 2023 Sep 29;18:5531-5559. doi: 10.2147/IJN.S424872. eCollection 2023.
7
Anti-Cancer Potential of Transiently Transfected HER2-Specific Human Mixed CAR-T and NK Cell Populations in Experimental Models: Initial Studies on Fucosylated Chondroitin Sulfate Usage for Safer Treatment.实验模型中瞬时转染的HER2特异性人混合CAR-T和NK细胞群体的抗癌潜力:关于使用岩藻糖基化硫酸软骨素进行更安全治疗的初步研究
Biomedicines. 2023 Sep 18;11(9):2563. doi: 10.3390/biomedicines11092563.
8
Site-specific transgene integration in chimeric antigen receptor (CAR) T cell therapies.嵌合抗原受体(CAR)T细胞疗法中的位点特异性转基因整合
Biomark Res. 2023 Jul 4;11(1):67. doi: 10.1186/s40364-023-00509-1.
9
Ablation of SYK Kinase from Expanded Primary Human NK Cells via CRISPR/Cas9 Enhances Cytotoxicity and Cytokine Production.通过 CRISPR/Cas9 敲除扩增的原代人自然杀伤细胞中的 SYK 激酶增强其细胞毒性和细胞因子产生。
J Immunol. 2023 Apr 15;210(8):1108-1122. doi: 10.4049/jimmunol.2200488.
10
Natural Killer Cell-Based Immunotherapy against Glioblastoma.基于自然杀伤细胞的胶质母细胞瘤免疫疗法。
Int J Mol Sci. 2023 Jan 20;24(3):2111. doi: 10.3390/ijms24032111.

本文引用的文献

1
Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer.嵌合抗原受体表达的自然杀伤细胞用于癌症的免疫治疗。
Front Immunol. 2018 Feb 15;9:283. doi: 10.3389/fimmu.2018.00283. eCollection 2018.
2
New developments in immunotherapy for pediatric solid tumors.儿童实体瘤免疫治疗的新进展。
Curr Opin Pediatr. 2018 Feb;30(1):30-39. doi: 10.1097/MOP.0000000000000564.
3
Engineering Natural Killer Cells for Cancer Immunotherapy.用于癌症免疫治疗的工程化自然杀伤细胞
Mol Ther. 2017 Aug 2;25(8):1769-1781. doi: 10.1016/j.ymthe.2017.06.012. Epub 2017 Jun 28.
4
Genome editing via delivery of Cas9 ribonucleoprotein.通过递送Cas9核糖核蛋白进行基因组编辑。
Methods. 2017 May 15;121-122:9-15. doi: 10.1016/j.ymeth.2017.04.003. Epub 2017 Apr 12.
5
Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection.利用CRISPR/Cas9将嵌合抗原受体(CAR)靶向至T细胞受体α恒定区(TRAC)基因座可增强肿瘤排斥反应。
Nature. 2017 Mar 2;543(7643):113-117. doi: 10.1038/nature21405. Epub 2017 Feb 22.
6
Efficient DNA-free genome editing of bread wheat using CRISPR/Cas9 ribonucleoprotein complexes.利用 CRISPR/Cas9 核糖核蛋白复合物高效编辑面包小麦的无 DNA 基因组。
Nat Commun. 2017 Jan 18;8:14261. doi: 10.1038/ncomms14261.
7
Genomic Profiling of a Large Set of Diverse Pediatric Cancers Identifies Known and Novel Mutations across Tumor Spectra.对大量不同类型儿童癌症进行基因组分析,发现了肿瘤谱中的已知和新突变。
Cancer Res. 2017 Jan 15;77(2):509-519. doi: 10.1158/0008-5472.CAN-16-1106. Epub 2017 Jan 9.
8
Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles.使用可生物还原脂质纳米颗粒高效递送基因组编辑蛋白。
Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):2868-73. doi: 10.1073/pnas.1520244113. Epub 2016 Feb 29.
9
TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway.TGF-β 通过抑制 mTOR 通路来抑制 NK 细胞的激活和功能。
Sci Signal. 2016 Feb 16;9(415):ra19. doi: 10.1126/scisignal.aad1884.
10
Genetic Manipulation of NK Cells for Cancer Immunotherapy: Techniques and Clinical Implications.用于癌症免疫治疗的自然杀伤细胞基因操作:技术与临床意义
Front Immunol. 2015 Jun 10;6:266. doi: 10.3389/fimmu.2015.00266. eCollection 2015.